Pharmaceutical Dissolution Testing Products and Services

Dissolution testing allows for the examination and prediction of the in-vitro behavior of pharmaceutical formulations. Drug release behavior of pre-formulations is made possible by the use of specialized dissolution equipment. By dissolution testing, a researcher can simulate the behavior of capsule, bead, and enteric-coated tablets in-vitro.

Important Applications of Dissolution Testing

  • Quality Control
  • Replicating certain mechanisms of in-vitro drug release
  • Determining if drug behavior meets regulatory standards
  • Dissolution simulation when choosing pharmaceutical excipients

Examples of Pharmaceutical Dissolution Equipment

Paddle apparatus dissolution testing is used to simulate tablet behavior in the gastrointestinal tract. The release behavior of implants and transdermal medications can also be tested with dissolution equipment. The reciprocating cylinder dissolution apparatus ("Bio-Dis") is excellent for examining the dissolution behavior of extended release products. Dissolution analysis is key in determining the homogeneity of the final pharmaceutical product. Whether controlled by the bench user or fully automated, the implementation of a dissolution testing protocol is crucial in the final stages of drug development to ensure the efficacy, safety, and marketability of the final compound.
  • From Data to Tissue

    Thursday, September 17, 2026
    The national-security regulatory landscape now layers a geopolitical framework onto the data flows, sample logistics, and vendor relationships that make modern clinical research possible. This architecture will not simplify. The DSP’s country-of-concern list may expand, the BIOSECURE Act’s ... read more
  • Upperton Receives MHRA License for Sterile Manufacturing Facility

    Thursday, September 17, 2026
    Upperton has received approval from the U.K. Medicines and Healthcare products Regulatory Agency for a variation to its Manufacturing and Importation Authorisation for Investigational Medicinal Products license covering a new sterile manufacturing facility in Nottingham. read more
  • ProBio, Kun Tuo Partner on Advanced-Therapy Trials in China

    Wednesday, September 16, 2026
    ProBio and Kun Tuo, an IQVIA company, have formed a strategic collaboration to provide development, manufacturing and clinical-operations support for biologics and cell and gene therapies in China. read more
  • Piramal Adds 4.3-MWp Solar Plant at UK Site

    Wednesday, September 16, 2026
    Piramal Pharma Solutions is installing a 4.3-MWp ground-mounted solar power plant at its integrated drug-substance and drug-product facility in Morpeth, United Kingdom. read more
  • We Have More Data Than We Know What to Do With

    Wednesday, September 16, 2026
    Every year brings another round of headlines about pharma “drowning in data.” At this point, that’s less a warning than a permanent weather condition. read more
We're sorry, no matching articles were found. Please select different filter options and try your search again.
We're sorry, no matching articles were found. Please select different filter options and try your search again.